TREATMENT OF MDS AND AML IN THE ERA OF VENETOCLAX

March 1, 2023
  • Community hospital physicians are seeing an increase in acute leukemia cases and need to be knowledgeable of the latest treatment options/guidelines for care of these patients in community & tertiary settings. Venetoclax use in treatment of MDS and AML has improved outcomes in cancer care and use continues to evolve. The options and recommended therapies for MDS and AML in the era of Venetoclax will provide knowledge, review treatment guidelines as well as best practices for management and treatment of these diseases.

Target Audience

  • Fellows
  • Medical Students
  • Nurse
  • Nurse Practitioners
  • Physicians
  • Physician Assistants
  • Pharmacy Technicians
  • Pharmacists
  • Residents

Learning Objectives

1. Review recent data on classification and prognosis of AML

2. Review the data on venetoclax-based induction for AML and high-grade MDS

3. Provide practical advice on how to use venetoclax in this patient population

Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 ANCC
  • 1.00 Attendance
  • 0.10 IACET CEU
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)
Registration Opens: 
03/01/2023
Registration Expires: 
03/01/2025
Activity Starts: 
03/01/2023 - 12:00pm EST
Activity Ends: 
03/01/2023 - 1:00pm EST
Rating: 
0
Durham, NC 27705
United States
  • Linda Sutton, MD
  • Sally Barbour
  • Tracey Torgeson, NP
  • Catherine Gaines, PA
  • Pamela Scarborough, RPHT CPHT III 
  • Cheri Young
  • Mark J. Levis, MD, PhD
  • ACPE - Pharmacy Technician
  • ACPE - Pharmacist
  • AMA PRA Category 1 Credit(s)
  • ANCC
  • Attendance
  • IACET CEU
  • JA Credit - AH

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 ANCC
  • 1.00 Attendance
  • 0.10 IACET CEU
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)
Please login or register to take this course.